Should you still hold Palantir (PLTR)?

Helm tracks 3 reasons to own PLTR: Government revenue stays sticky and keeps growing; US commercial revenue accelerates as AIP deployments convert pilots into contracts; Rule-of-40 expansion and accelerating revenue justify a premium multiple. As of the latest evidence, the thesis reads not yet verified against new evidence, based on dated SEC-filing and news evidence tested against each reason. This is research, not investment advice.

What would break the PLTR bull case?

Each reason to own PLTR has a defined breaking point. The bull case weakens if: A major government contract is cancelled, not renewed, or put under review; US commercial revenue growth decelerates or AIP customer count growth stalls; Revenue growth decelerates while the stock still trades at an extreme sales multiple. Helm watches these against new filings and news and flags the moment one is contradicted.

Is the PLTR thesis still intact?

Helm's computed status for the PLTR thesis is not yet verified against new evidence, derived from 0 dated pieces of evidence scored against its pillars. Each pillar is rated intact, watch, weakening, or broken.

Living thesis · tracked against the evidence

Palantir PLTR

Unverified

The reasons to own PLTR, the single fact that would break each one, and the dated filing and news evidence Helm has tested against them. Status is computed from that evidence, not hand-set.

Watch your own PLTRthesis →

Watch my tickers

Helm reads the filings so you don't have to.

Get an email when something changes on your tickers: the exact quote, dated and sourced. No account, no brokerage connection, unsubscribe anytime.

Government revenue stays sticky and keeps growing
Unverified
Breaks if: A major government contract is cancelled, not renewed, or put under review
No filing or news has tested this thesis since monitoring began.
US commercial revenue accelerates as AIP deployments convert pilots into contracts
Unverified
Breaks if: US commercial revenue growth decelerates or AIP customer count growth stalls
No filing or news has tested this thesis since monitoring began.
Rule-of-40 expansion and accelerating revenue justify a premium multiple
Unverified
Breaks if: Revenue growth decelerates while the stock still trades at an extreme sales multiple
No filing or news has tested this thesis since monitoring began.

Research, not investment advice. Helm surfaces the evidence; you decide. This page tracks what to watch on the thesis, not whether to buy or sell.

Helm watches this thesis in public. It watches yours in private.

Watch your own PLTR thesis →

The feedPLTR snapshot